[1]
Junaidi, A., Sabrina Ermayanti and Afriani Afriani 2022. Benefits of Conventional Chemotherapy in Progressive Disease Patients with Tyrosine-Kinase Inhibitors: A Case Report. Bioscientia Medicina : Journal of Biomedicine and Translational Research. 6, 14 (Oct. 2022), 2625-2633. DOI:https://doi.org/10.37275/bsm.v6i14.657.